04:10:20 EST Sat 07 Feb 2026
Enter Symbol
or Name
USA
CA



Z:EVH - EVOLENT HEALTH INC - https://www.evolenthealth.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
EVH - Z0.42.78·8.600.22.85-0.055-1.92,872.37,4118,1502.88  2.94  2.8212.065  2.8918:10:33Feb 0415 min RT 2¢

Recent Trades - Last 10 of 8150
Time ETExPriceChangeVolume
18:10:33Z2.8596-0.030420
17:55:39Z2.86-0.03100
17:54:56Z2.8596-0.0304500
17:35:44Z2.86-0.032
17:35:43Z2.86-0.032
17:35:42Z2.86-0.032
17:35:42Z2.86-0.032
17:35:41Z2.86-0.032
17:35:40Z2.86-0.032
17:35:40Z2.86-0.032

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-02-04 11:02U:EVHNews ReleaseEvolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026
2026-01-02 16:15U:EVHNews ReleaseEvolent Reports Inducement Award Under NYSE Listing Rule 303A.08
2025-11-11 08:30U:EVHNews ReleaseGlobal Digital Health Market Size Projected to Reach $1.5 Trillion By 2032 as A.I. Technology Enhances Operations
2025-11-06 16:12U:EVHNews ReleaseEvolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden
2025-11-06 16:10U:EVHNews ReleaseEvolent Announces Third Quarter 2025 Results
2025-10-09 08:30U:EVHNews ReleaseEvolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025
2025-09-23 16:10U:EVHNews ReleaseEvolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners
2025-09-23 16:10U:EVHNews ReleasePrivia Health Expands Value-Based Care Footprint with Acquisition of Accountable Care Organization Business from Evolent Health
2025-08-19 07:00U:EVHNews ReleaseEvolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock
2025-08-18 16:05U:EVHNews ReleaseEvolent Health, Inc. Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock
2025-08-07 16:10U:EVHNews ReleaseEvolent Announces Second Quarter 2025 Results
2025-07-29 08:55U:EVHNews ReleaseNYSE Content Advisory: Pre-market update + Wall Street anticipates Fed's next move
2025-07-14 08:00U:EVHNews ReleaseEvolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025
2025-07-09 08:00U:EVHNews ReleaseEvolent announces key appointments to leadership team
2025-06-20 06:30U:EVHNews ReleaseEvolent reiterates Q2 and full year guidance for Adjusted EBITDA
2025-05-08 16:10U:EVHNews ReleaseEvolent Announces First Quarter 2025 Results
2025-04-22 06:30U:EVHNews ReleaseEvolent names Shawn Guertin as new independent nominee for election to its Board of Directors
2025-04-15 09:00U:EVHNews ReleaseEvolent program achieves 20% reduction in use of low-value oncology regimens
2025-04-10 17:00U:EVHNews ReleaseEvolent To Release First Quarter 2025 Financial Results on Thursday, May 8, 2025